Figlin RA - Search Results

1

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.

Jonasch E, Stadler WM, Bukowski RM, Hayes TG, Varadhachary A, Malik R, Figlin RA, Srinivas S. Jonasch E, et al. Among authors: figlin ra. Cancer. 2008 Jul 1;113(1):72-7. doi: 10.1002/cncr.23519. Cancer. 2008. PMID: 18484647 Free article. Clinical Trial.

2

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J. Ganz PA, et al. Among authors: figlin ra. Cancer. 1989 Apr 1;63(7):1271-8. doi: 10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6. Cancer. 1989. PMID: 2465815 Clinical Trial.

3

Interferon in renal cell carcinoma. The UCLA experience.

Sarna G, Figlin R, de Kernion J. Sarna G, et al. Cancer. 1987 Feb 1;59(3 Suppl):610-2. doi: 10.1002/1097-0142(19870201)59:3+<610::aid-cncr2820591306>3.0.co;2-f. Cancer. 1987. PMID: 3542184 Clinical Trial.

4

Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.

Figlin RA, deKernion JB, Maldazys J, Sarna G. Figlin RA, et al. Cancer Treat Rep. 1985 Mar;69(3):263-7. Cancer Treat Rep. 1985. PMID: 3978656

5

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.

Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB, Belldegrun A. Hathorn RW, et al. Cancer. 1994 Oct 1;74(7):1904-11. doi: 10.1002/1097-0142(19941001)74:7<1904::aid-cncr2820740713>3.0.co;2-b. Cancer. 1994. PMID: 7521786

6

The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.

Steger GG, Kaboo R, deKernion JB, Figlin R, Belldegrun A. Steger GG, et al. Br J Cancer. 1995 Jul;72(1):101-7. doi: 10.1038/bjc.1995.284. Br J Cancer. 1995. PMID: 7599037 Free PMC article.

7

Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferon.

Whitehead RP, Hauschild A, Christophers E, Figlin R. Whitehead RP, et al. Cancer Biother. 1995 Spring;10(1):45-51. doi: 10.1089/cbr.1995.10.45. Cancer Biother. 1995. PMID: 7780486

8

Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.

Janik JE, Sznol M, Urba WJ, Figlin R, Bukowski RM, Fyfe G, Pierce WC, Belldegrun A, Sharfman WH, Smith JW 2nd, et al. Janik JE, et al. Cancer. 1993 Nov 1;72(9):2656-9. doi: 10.1002/1097-0142(19931101)72:9<2656::aid-cncr2820720922>3.0.co;2-a. Cancer. 1993. PMID: 8402486

9

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.

Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB. Figlin RA, et al. Cancer. 1996 Sep 1;78(5):998-1003. doi: 10.1002/(SICI)1097-0142(19960901)78:5<998::AID-CNCR9>3.0.CO;2-8. Cancer. 1996. PMID: 8780537 Clinical Trial.

10

Current management of renal cell carcinoma.

Sokoloff MH, deKernion JB, Figlin RA, Belldegrun A. Sokoloff MH, et al. Among authors: figlin ra. CA Cancer J Clin. 1996 Sep-Oct;46(5):284-302. doi: 10.3322/canjclin.46.5.284. CA Cancer J Clin. 1996. PMID: 8806394 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters